通过细胞循环加速和免疫微环境修饰,MORC2促进胆管癌的进展
Shizhuan Huang1, Zhizhou Li2, Haotian Wu3
1Department of Hepatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, People's Republic of China. hsz0717@163.com.
Cellular and molecular biology (Noisy-le-Grand, France)
|April 26, 2025
概括
这项研究确定了Microrchidia家族CW型指2 (MORC2) 作为胆管癌 (CCA) 进展的关键驱动因素. 向MORC2可能通过抑制瘤生长和改变瘤微环境,为晚期CCA提供一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 胆管癌 (CCA) 是一种致命的上皮性恶性瘤,治疗选择有限.
- 确定新的治疗点对于改善晚期CCA患者的治疗结果至关重要.
研究的目的:
- 研究Microrchidia家族CW型指2 (MORC2) 作为不可切割的高级CCA中的治疗标的作用.
- 阐明MORC2在CCA细胞增殖和瘤微环境中的参与.
主要方法:
- 生物信息学分析被用来研究MORC2在CCA中的功能.
- 这项研究的重点是MORC2与细胞循环调节的关联以及瘤的免疫抑制微环境.
主要成果:
- MORC2通过通过TNF-α/NFKB信号传递促进细胞周期进展来加速CCA细胞增殖.
- 低调MORC2诱导细胞循环停止,并可能通过上调CCL3.3,增强中性粒细胞透.
- MORC2显著影响CCA细胞增殖和免疫抑制瘤微环境.
结论:
- MORC2是CCA进展的关键因素,影响瘤生长和免疫逃避.
- 向MORC2代表了一个有前途的新型治疗策略,用于晚期胆管癌.
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
The Tumor Microenvironment
6.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.4K
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Adaptive Mechanisms in Cancer Cells
5.5K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.5K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K


